COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
发明人:
Franck MOUTHON,Mathieu CHARVERIAT
申请号：
US15903662
公开号：
US20180177773A1
申请日:
2018.02.23
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This invention relates to improvements in therapeutic neurological and neuropsychic treatments using acetylcholinesterase inhibitors. More specifically, the invention enables the effects of the reversible acetylcholinesterase inhibitor donepezil to be potentiated by certain molecules, referred to here as connexin-blocking agents. Said connexin-blocking agent is preferably meclofenamic acid.
